Haiping Zhang
137 South Liyushan Road
Ueruemqi, 830054, China
Ueruemqi, 830054, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Lipidomic and transcriptomic analysis and its therapeutic implications in Chinese Kazakh patients with esophageal squamous cell carcinoma.
Journal: BMC cancer
Published: September 27, 2024
Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 20, 2023
Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.
Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.
Journal: Journal of immunology research
Published: March 17, 2022
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: October 30, 2017
A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
Journal: Molecular medicine reports
Published: October 13, 2017
Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
Journal: Biochemical and biophysical research communications
Published: June 28, 2017
RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Journal: International journal of oncology
Published: June 14, 2017
Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 21, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026